214 related articles for article (PubMed ID: 31054897)
1. Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.
Perrino CM; Eble J; Kao CS; Whaley RD; Cheng L; Idrees M; Hashemi-Sadraei N; Monn MF; Kaimakliotis HZ; Bandali E; Grignon D
Hum Pathol; 2019 Aug; 90():27-36. PubMed ID: 31054897
[TBL] [Abstract][Full Text] [Related]
2. [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases].
Zhang W; Jiang YX; Liu Y; Yu WJ; Zhao H; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):433-7. PubMed ID: 24246859
[TBL] [Abstract][Full Text] [Related]
3. Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder.
Nomura S; Suzuki Y; Akatsuka J; Endo Y; Shimizu A; Hamasaki T; Kimura G; Kondo Y
BMC Urol; 2020 Jun; 20(1):72. PubMed ID: 32571273
[TBL] [Abstract][Full Text] [Related]
4. Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review.
Wang Z; Lu T; Du L; Hu Z; Zhuang Q; Li Y; Wang CY; Zhu H; Ye Z
Int J Clin Exp Pathol; 2012; 5(6):601-8. PubMed ID: 22949945
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder.
Borhan WM; Cimino-Mathews AM; Montgomery EA; Epstein JI
Am J Surg Pathol; 2017 Nov; 41(11):1570-1575. PubMed ID: 28786878
[TBL] [Abstract][Full Text] [Related]
6. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
Chan E; Garg K; Stohr BA
Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
[TBL] [Abstract][Full Text] [Related]
7. High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants.
Perez-Montiel D; Wakely PE; Hes O; Michal M; Suster S
Mod Pathol; 2006 Apr; 19(4):494-503. PubMed ID: 16474378
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma.
Lim MG; Adsay NV; Grignon DJ; Osunkoya AO
Mod Pathol; 2011 Feb; 24(2):241-7. PubMed ID: 20818341
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid urothelial carcinoma of the urinary bladder: a case report and immunohistochemical study.
Sato K; Ueda Y; Kawamura K; Aihara K; Katsuda S
Pathol Res Pract; 2009; 205(3):189-94. PubMed ID: 19041193
[TBL] [Abstract][Full Text] [Related]
10. p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas.
Goto K; Konomoto T; Hayashi K; Kinukawa N; Naito S; Kumazawa J; Tsuneyoshi M
Mod Pathol; 1997 May; 10(5):428-37. PubMed ID: 9160306
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
[TBL] [Abstract][Full Text] [Related]
12. Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis.
Jones TD; Zhang S; Lopez-Beltran A; Eble JN; Sung MT; MacLennan GT; Montironi R; Tan PH; Zheng S; Baldridge LA; Cheng L
Am J Surg Pathol; 2007 Dec; 31(12):1861-7. PubMed ID: 18043040
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Pitfalls in Genitourinary Pathology: 2018 Update.
Cox RM; Magi-Galluzzi C; McKenney JK
Adv Anat Pathol; 2018 Nov; 25(6):387-399. PubMed ID: 30157041
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases.
Fox MD; Xiao L; Zhang M; Kamat AM; Siefker-Radtke A; Zhang L; Dinney CP; Czerniak B; Guo CC
Am J Clin Pathol; 2017 May; 147(5):500-506. PubMed ID: 28371875
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic algorithm of urothelial tumor of the upper urinary tract].
Höltl W
Urologe A; 2001 Nov; 40(6):451. PubMed ID: 11760348
[No Abstract] [Full Text] [Related]
16. CD138 Expression Is Observed in the Urothelial Epithelium and in Various Urothelial Carcinomas, and Cannot Be Evidence for Plasmacytoid Urothelial Carcinoma.
Goto K
Int J Surg Pathol; 2016 Oct; 24(7):614-9. PubMed ID: 27305940
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder.
Paner GP; Annaiah C; Gulmann C; Rao P; Ro JY; Hansel DE; Shen SS; Lopez-Beltran A; Aron M; Luthringer DJ; De Peralta-Venturina M; Cho Y; Amin MB
Hum Pathol; 2014 Jul; 45(7):1473-82. PubMed ID: 24780825
[TBL] [Abstract][Full Text] [Related]
18. The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma.
Keck B; Stoehr R; Wach S; Rogler A; Hofstaedter F; Lehmann J; Montironi R; Sibonye M; Fritsche HM; Lopez-Beltran A; Epstein JI; Wullich B; Hartmann A
Int J Cancer; 2011 Jul; 129(2):346-54. PubMed ID: 20878954
[TBL] [Abstract][Full Text] [Related]
19. Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series.
Raspollini MR; Sardi I; Giunti L; Di Lollo S; Baroni G; Stomaci N; Menghetti I; Franchi A
Hum Pathol; 2011 Aug; 42(8):1149-58. PubMed ID: 21334719
[TBL] [Abstract][Full Text] [Related]
20. Synchronous squamous cell carcinoma of the kidney, squamous cell carcinoma of the ureter, and sarcomatoid carcinoma of the urinary bladder: a case report.
Terada T
Pathol Res Pract; 2010 Jun; 206(6):379-83. PubMed ID: 19766408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]